The best way to value Ensco (ESV), and the offshore oil drillers more generally, is to value them on the basis of their assets. These companies are obviously not earning any money right now, and when they do earn money, their earnings are very cyclical in nature, thus making earnings based analyses (like DCF’s) that make projections of regular earnings into the future inapplicable. So, in....More>>>
1. Topsy-turvy stocks: The volatility of the past few trading days could continue into Wednesday.
U.S. stock futures are moving down, indicating all the major indexes could drop by about 1% at the open.
Meanwhile, European markets are in recovery mode after falling by 2% to 3% on Tuesday.
News that German Chancellor Angela Merkel had struck a deal with her center-left....More>>>
Italy’s biggest bank plans to raise 13 billion ($13.8 billion) and slash thousands of jobs to shore up its finances.
The sweeping overhaul announced Tuesday by UniCredit SpA will push the total number of expected job losses at the Milan-based bank to 14,000 by 2019. That’s about 10% of its employees.
The job cuts will reduce costs by 1.1 billion ($1.2 billion).
Social Security may be one of your largest assets. What and when you collect will make a huge difference to your lifetime benefits.
Today’s column explores filing for widow’s benefits, providing for disabled siblings and divorce. Larry Kotlikoff is the founder and president of Economic Security Planning, a company that markets Maximize My Social Security, a Social Security benefits....More>>>
For our first post of 2017, we look at a small biotech concern that has an intriguing pipeline along with recent insider buying and a collaboration deal with a pharma giant.
Calithera Biosciences (NASDAQ:CALA) is a South San Francisco, CA based clinical-stage pharmaceutical company focused on developing novel small molecule drugs directed against tumor metabolism....More>>>
Raven Industries(NASDAQ:RAVN)announced fiscal first-quarter 2018 results on Monday after the market closed, including strong growth across all segments, led by a nearly 50% increase from engineered films. Let’s take a closer look both at what drove business at the mini-industrial conglomerate as it kicked off the new fiscal year, and at what investors can expect going forward.
You might be wondering if David’s Tea (NASDAQ: DTEA) is good value after its epic earnings miss. Though the valuation has never been this compelling from a numbers perspective, the numbers in this case do not tell the whole story.
I last wrote about David’s Tea on March 9th, in an article titled “Is the worst over?”. The company had put the botched IPO behind....More>>>
If your company only offers a 401(k), health insurance and a flexible vacation schedule, then you’re missing out on the hottest employee benefit of 2017: student loan repayment assistance.
To attract and retain millennials, in particular, companies are expanding their employee benefit programs to help reduce student loan debt for their employees. Millennials are heeding the call.
Trump to Direct DOL to Delay Fiduciary Rule: Sources
Trump Issues Order to Knock Out 2 Regs for Every New One
Trump Order to Delay DOL Fiduciary Rule Said to Be Coming Soon
Pershing announced Wednesday afternoon that Lori Hardwick will be leaving her position as chief operating officer at the firm this week, after only 11 months as the No. 2 executive at the Jersey City, New....More>>>
An FDA decision about another drug makers Duchenne muscular dystrophy therapy is spelling bad news for Sarepta Therapeutics (SRPT).
The FDA declined a request from Swiss biotech Santhera for accelerated approval of Raxone, its treatment for the rare disorder. The agency said the drug company needs to perform another study to confirm previous results.
Sarepta, meanwhile, is awaiting....More>>>